DreaMed Diabetes, developer of diabetes treatment and management solutions, announced today that it had signed an exclusive worldwide development and license agreement with Medtronic, the world's premier medical technology and services company, for the development and marketing of products incorporating DreaMed’s MD-Logic Artificial Pancreas algorithm in Medtronic’s insulin pumps.
from The Medical News http://ift.tt/1yRw3BA
from The Medical News http://ift.tt/1yRw3BA
No comments:
Post a Comment